| Year |
Title |
Altmetric |
| 2023
|
Regional Variation in Hormonal and Metabolic Parameters of White and Black Women With PCOS in the United States.
Journal of Clinical Endocrinology and Metabolism.
108:706-712.
2023
|
|
| 2023
|
Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome.
Diagnostics.
13.
2023
|
|
| 2023
|
Establishing Normative Values to Determine the Prevalence of Biochemical Hyperandrogenism in Premenopausal Women of Different Ethnicities from Eastern Siberia.
Diagnostics.
13.
2023
|
|
| 2023
|
The polycystic ovary syndrome: the first 150 years of study.
F&S Reports.
2023
|
|
| 2022
|
Ovarian volume as an independent marker for metabolic dysfunction in women with suspected androgen excess.
F&S Reports.
3:366-371.
2022
|
|
| 2022
|
History of Polycystic Ovary Syndrome, Premature Adrenarche, and Hyperandrogenism in Pediatric Endocrinology
2022
|
|
| 2022
|
Where Are We in Understanding the Natural History of Polycystic Ovary Syndrome? A Systematic Review of Longitudinal Cohort Studies.
Obstetrical and Gynecological Survey.
77:535-536.
2022
|
|
| 2022
|
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
Frontiers in Endocrinology.
13.
2022
|
|
| 2022
|
Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies.
Human Reproduction.
37:1255-1273.
2022
|
|
| 2022
|
PCOS and Mendelian Randomization: Too Soon?.
Journal of Clinical Endocrinology and Metabolism.
107:E2195-E2196.
2022
|
|
| 2022
|
Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies.
Clinical Endocrinology.
96:475-498.
2022
|
|
| 2022
|
Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
Human Reproduction.
37:553-564.
2022
|
|
| 2022
|
Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.
Journal of Clinical Endocrinology and Metabolism.
107:E912-E923.
2022
|
|
| 2022
|
Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.
American Journal of Obstetrics and Gynecology.
226:187-204.e15.
2022
|
|
| 2022
|
Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences.
Journal of Clinical Endocrinology and Metabolism.
107:575-585.
2022
|
|
| 2021
|
Fertility evaluation of infertile women: a committee opinion.
Fertility and Sterility.
116:1255-1265.
2021
|
|
| 2021
|
Obesity and reproduction: a committee opinion.
Fertility and Sterility.
116:1266-1285.
2021
|
|
| 2021
|
Pcos phenotype in unselected populations study (P-pup): Protocol for a systematic review and defining pcos diagnostic features with pooled individual participant data.
Diagnostics.
11.
2021
|
|
| 2021
|
Systemic chronic subclinical inflammation, adipose tissue dysfunction, and polycystic ovary syndrome: three major forces intertwined.
Fertility and Sterility.
116:1147-1148.
2021
|
|
| 2021
|
Adiposity in polycystic ovary syndrome: excess versus dysfunction.
Fertility and Sterility.
116:87-88.
2021
|
|
| 2021
|
The Need to Reassess the Diagnosis of Polycystic Ovary Syndrome (PCOS): A Review of Diagnostic Recommendations from the International Evidence-Based Guideline for the Assessment and Management of PCOS.
Seminars in Reproductive Medicine.
39:71-77.
2021
|
|
| 2021
|
Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Fertility and Sterility.
115:1557-1568.
2021
|
|
| 2021
|
Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
American Journal of Obstetrics and Gynecology.
224:428-444.e8.
2021
|
|
| 2021
|
How polycystic ovary syndrome came into its own
2021
|
|
| 2021
|
Financial fluency: demystifying accounting and business planning for the reproductive medicine specialist.
Fertility and Sterility.
115:7-16.
2021
|
|
| 2020
|
Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (Nature Communications, (2015), 6, 1, (7502), 10.1038/ncomms8502).
Nature Communications.
11.
2020
|
|
| 2020
|
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion.
Fertility and Sterility.
114:1158-1164.
2020
|
|
| 2020
|
Testing and interpreting measures of ovarian reserve: a committee opinion.
Fertility and Sterility.
114:1151-1157.
2020
|
|
| 2020
|
Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction.
Journal of Clinical Endocrinology and Metabolism.
105.
2020
|
|
| 2020
|
The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome
2020
|
|
| 2020
|
Letter to the Editor: "Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations".
Journal of Clinical Endocrinology and Metabolism.
105.
2020
|
|
| 2020
|
Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.
Clinical Endocrinology.
93:163-172.
2020
|
|
| 2020
|
Adipocyte insulin resistance in PCOS: Relationship with GLUT-4 expression and whole-body glucose disposal and β-cell function.
Journal of Clinical Endocrinology and Metabolism.
105.
2020
|
|
| 2020
|
Environmental Pollutant Benzo[a]pyrene Induces Recurrent Pregnancy Loss through Promoting Apoptosis and Suppressing Migration of Extravillous Trophoblast.
BioMed Research International.
2020.
2020
|
|
| 2019
|
Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: An androgen excess and PCOS society resource.
Human Reproduction.
34:2254-2265.
2019
|
|
| 2019
|
Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines.
Trends in Endocrinology and Metabolism.
30:467-478.
2019
|
|
| 2019
|
Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non–insulin-mediated whole-body glucose uptake.
Clinical Endocrinology.
90:542-552.
2019
|
|
| 2019
|
Defining what is normal: the key to the diagnosis of polycystic ovary syndrome (and any other disorder for that matter…).
Fertility and Sterility.
111:681-682.
2019
|
|
| 2019
|
Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee.
Journal of Clinical Endocrinology and Metabolism.
104:2875-2891.
2019
|
|
| 2019
|
Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome—Based on liquid chromatography with tandem mass spectrometry measurements.
Journal of Clinical Laboratory Analysis.
33.
2019
|
|
| 2019
|
Complex diseases and co-morbidities: Polycystic ovary syndrome and type 2 diabetes mellitus.
Endocrine Connections.
8:R71-R75.
2019
|
|
| 2019
|
Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
Human Reproduction.
34:335-344.
2019
|
|
| 2019
|
Is antimüllerian hormone an early marker or an in utero effector of incipient polycystic ovary syndrome?.
Fertility and Sterility.
111:264-265.
2019
|
|
| 2019
|
Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.
Fertility and Sterility.
111:389-396.
2019
|
|
| 2019
|
The pressing need for standardization in epidemiologic studies of PCOS across the globe.
Gynecological Endocrinology.
35:1-3.
2019
|
|
| 2019
|
Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
Human Reproduction.
34:127-136.
2019
|
|
| 2019
|
FSH beyond fertility.
Frontiers in Endocrinology.
10.
2019
|
|
| 2018
|
Why we need epidemiologic studies of polycystic ovary syndrome in Africa.
International Journal of Gynecology and Obstetrics.
143:251-254.
2018
|
|
| 2018
|
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Human Reproduction.
33:1602-1618.
2018
|
|
| 2018
|
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Clinical Endocrinology.
89:251-268.
2018
|
|
| 2018
|
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Fertility and Sterility.
110:364-379.
2018
|
|
| 2018
|
Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
Journal of Women's Health.
27:892-902.
2018
|
|
| 2018
|
Reproductive endocrinology and infertility: Clinical expert series polycystic ovary syndrome.
Obstetrics and Gynecology.
132:321-336.
2018
|
|
| 2017
|
Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age?.
Fertility and Sterility.
108:959-960.
2017
|
|
| 2017
|
Health System Creation and Integration at a Health Sciences University: A Five-Year Follow-up
2017
|
|
| 2017
|
Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).
Clinical Chemistry and Laboratory Medicine.
55:1789-1797.
2017
|
|
| 2017
|
Genetic basis of eugonadal and hypogonadal female reproductive disorders.
Best Practice and Research: Clinical Obstetrics and Gynaecology.
44:3-14.
2017
|
|
| 2017
|
Letter to the Editor: “Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis”.
Journal of Clinical Endocrinology and Metabolism.
102:3865-3866.
2017
|
|
| 2017
|
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: An update with a special focus on adolescent and adult women.
Human Reproduction Update.
23:580-599.
2017
|
|
| 2017
|
Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: A pilot study.
Journal of Ovarian Research.
10.
2017
|
|
| 2017
|
Genetics of polycystic ovary syndrome
2017
|
|
| 2017
|
Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1.
Reproductive Sciences.
24:1005-1013.
2017
|
|
| 2017
|
PCOS: Animal models for PCOS-not the real thing.
Nature Reviews Endocrinology.
13:382-384.
2017
|
|
| 2017
|
Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines.
Cancer Cell International.
17.
2017
|
|
| 2017
|
Polycystic Ovarian Syndrome: Long-Term Health Consequences.
Seminars in Reproductive Medicine.
35:271-281.
2017
|
|
| 2017
|
Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Human Reproduction.
32:185-192.
2017
|
|
| 2017
|
Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?.
Journal of Clinical Endocrinology and Metabolism.
102:4421-4427.
2017
|
|
| 2016
|
Androgen excess: Investigations and management.
Best Practice and Research: Clinical Obstetrics and Gynaecology.
37:98-118.
2016
|
|
| 2016
|
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.
Fertility and Sterility.
106:1510-1520.e2.
2016
|
|
| 2016
|
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.
Journal of Women's Health.
25:875-881.
2016
|
|
| 2016
|
Polycystic ovary syndrome.
Nature Reviews Disease Primers.
2.
2016
|
|
| 2016
|
Criteria, prevalence, and phenotypes of polycystic ovary syndrome.
Fertility and Sterility.
106:6-15.
2016
|
|
| 2016
|
Evolutionary determinants of polycystic ovary syndrome: part 2.
Fertility and Sterility.
106:42-47.
2016
|
|
| 2016
|
Introduction: Determinants of polycystic ovary syndrome.
Fertility and Sterility.
106:4-5.
2016
|
|
| 2016
|
Erratum : PCOS in 2015: New insights into the genetics of polycystic ovary syndrome (Nature Reviews Endocrinology (2016) 12 (7475)) DOI:10.1038/nrendo.2015.230).
Nature Reviews Endocrinology.
12:183.
2016
|
|
| 2016
|
Association study of androgen signaling pathway genes in polycystic ovary syndrome.
Fertility and Sterility.
105:467-473.e4.
2016
|
|
| 2016
|
PCOS in 2015: New insights into the genetics of polycystic ovary syndrome.
Nature Reviews Endocrinology.
12:74.
2016
|
|
| 2016
|
Stein and Leventhal: 80 years on.
American Journal of Obstetrics and Gynecology.
214:247.e1-247.e11.
2016
|
|
| 2015
|
Basal metabolic rate in women with PCOS compared to eumenorrheic controls.
Clinical Endocrinology.
83:384-388.
2015
|
|
| 2015
|
Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.
Nature Communications.
7.
2015
|
|
| 2015
|
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.
Nature Communications.
6.
2015
|
|
| 2015
|
Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.
PLoS Genetics.
11.
2015
|
|
| 2015
|
Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al.
Journal of Clinical Endocrinology and Metabolism.
100.
2015
|
|
| 2015
|
Berberine inhibits the proliferation of human uterine leiomyoma cells.
Fertility and Sterility.
103:1098-1106.
2015
|
|
| 2015
|
Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome
2015
|
|
| 2015
|
DHEA, DHEAS and PCOS
2015
|
|
| 2015
|
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals.
Journal of Clinical Endocrinology and Metabolism.
100:E182-E186.
2015
|
|
| 2015
|
MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue.
Journal of Diabetes Research.
2015.
2015
|
|
| 2014
|
Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness the coronary artery risk development in young adults women's study
2014
|
|
| 2014
|
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
99:E2754-E2761.
2014
|
|
| 2014
|
Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS
2014
|
|
| 2014
|
Artist's statement: Paranoia.
Academic Medicine.
89:549.
2014
|
|
| 2014
|
Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Human Reproduction.
29:1508-1517.
2014
|
|
| 2014
|
Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: A case-control study.
BMC Endocrine Disorders.
14.
2014
|
|
| 2014
|
Polycystic ovary syndrome: What's in a name?.
Journal of Clinical Endocrinology and Metabolism.
99:1142-1145.
2014
|
|
| 2014
|
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
Fertility and Sterility.
101.
2014
|
|
| 2014
|
What Is the Value and Role of Academic Medicine in the Life of Its University?.
Academic Medicine.
89:208-211.
2014
|
|
| 2013
|
Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome.
BioMed Research International.
2013.
2013
|
|
| 2013
|
The severity of menstrual dysfunction as a predictor of insulin resistance in pcos.
Journal of Clinical Endocrinology and Metabolism.
98.
2013
|
|
| 2013
|
Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS.
Clinical Endocrinology.
79:550-557.
2013
|
|
| 2013
|
Implementing a teaching service for voluntary faculty in obstetrics and gynecology: Long-term results
2013
|
|
| 2013
|
Polycystic ovary syndrome, microbiomics and why you should be a little selfish with your time.
Expert Review of Endocrinology and Metabolism.
8:329-331.
2013
|
|
| 2013
|
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
98.
2013
|
|
| 2013
|
Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.
Journal of Clinical Endocrinology and Metabolism.
98:1541-1548.
2013
|
|
| 2013
|
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome.
Fertility and Sterility.
99:599-604.
2013
|
|
| 2013
|
Mirna-93 inhibits glut4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance.
Diabetes.
62:2278-2286.
2013
|
|
| 2012
|
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.
Obstetrical and Gynecological Survey.
67:707-709.
2012
|
|
| 2012
|
Erratum: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysis (Diabetologia DOI 10.1007/s00125-012-2638-6).
Diabetologia.
55:2858-2859.
2012
|
|
| 2012
|
Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.
Molecular Human Reproduction.
18:498-509.
2012
|
|
| 2012
|
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.
Journal of Clinical Endocrinology and Metabolism.
97.
2012
|
|
| 2012
|
Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.
Molecular Human Reproduction.
18:320-324.
2012
|
|
| 2012
|
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
97.
2012
|
|
| 2012
|
Metabolic and cardiovascular genes in polycystic ovary syndrome: A candidate-wide association study (CWAS).
Steroids.
77:317-322.
2012
|
|
| 2012
|
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts.
Journal of Medical Genetics.
49:90-95.
2012
|
|
| 2012
|
A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause
2012
|
|
| 2012
|
Identifying and Developing Leadership Competencies in Health Research Organizations: A Pilot Study..
The Journal of health administration education.
29:135-154.
2012
|
|
| 2012
|
Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: A systematic review and meta-analysis.
Diabetologia.
55:2636-2645.
2012
|
|
| 2011
|
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys.
PLoS One.
6.
2011
|
|
| 2011
|
Defining hirsutism in Chinese women: A cross-sectional study.
Fertility and Sterility.
96:792-796.
2011
|
|
| 2011
|
New name, school still addressing physician shortages in Georgia..
Journal of the Medical Association of Georgia.
100.
2011
|
|
| 2011
|
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome.
Fertility and Sterility.
95.
2011
|
|
| 2011
|
Congenital Adrenal Hyperplasia.
Journal of Pediatric and Adolescent Gynecology.
24:116-126.
2011
|
|
| 2011
|
Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.
PLoS One.
6.
2011
|
|
| 2011
|
Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: Evidence of cell plasticity.
PLoS One.
6.
2011
|
|
| 2011
|
Fifteen-year trend in the use of male reproductive surgery: Analysis of the healthcare cost and utilization project data.
BJU International.
107:1118-1123.
2011
|
|
| 2011
|
Polycystic ovary syndrome: An ancient disorder?.
Fertility and Sterility.
95:1544-1548.
2011
|
|
| 2011
|
Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis.
Nature Reviews Endocrinology.
7:219-231.
2011
|
|
| 2011
|
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Obstetrical and Gynecological Survey.
66:143-144.
2011
|
|
| 2011
|
Socioeconomic status and polycystic ovary syndrome.
Journal of Women's Health.
20:413-419.
2011
|
|
| 2011
|
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome.
PLoS One.
6.
2011
|
|
| 2011
|
Reanalyzing the modified Ferriman-Gallwey score: Is there a simpler method for assessing the extent of hirsutism?.
Fertility and Sterility.
96.
2011
|
|
| 2011
|
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.
Fertility and Sterility.
95.
2011
|
|
| 2010
|
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology & Metabolism (2010) 95 (4133-4160)).
Journal of Clinical Endocrinology and Metabolism.
95:5137.
2010
|
|
| 2010
|
Evaluating professionalism, practice-based learning and improvement, and systems-based practice: utilization of a compliance form and correlation with conflict styles..
Journal of graduate medical education.
2:423-429.
2010
|
|
| 2010
|
Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.
Fertility and Sterility.
94:690-693.
2010
|
|
| 2010
|
Response to Letter to the Editor.
Maturitas.
66:329-330.
2010
|
|
| 2010
|
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Fertility and Sterility.
94:684-689.
2010
|
|
| 2010
|
Association study of four key folliculogenesis genes in polycystic ovary syndrome.
BJOG: an International Journal of Obstetrics and Gynaecology.
117:756-760.
2010
|
|
| 2010
|
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome.
Digestive Diseases and Sciences.
55:1085-1089.
2010
|
|
| 2010
|
Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.
Fertility and Sterility.
93:1938-1941.
2010
|
|
| 2010
|
Promoting residents' professional development and academic productivity using a structured faculty mentoring program
2010
|
|
| 2010
|
Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question.
Maturitas.
65:297-298.
2010
|
|
| 2010
|
The Associations Between Residents' Behavior and the Thomas-Kilmann Conflict MODE Instrument..
Journal of graduate medical education.
2:118-125.
2010
|
|
| 2010
|
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency..
International Journal of Pediatric Endocrinology.
2010:494173.
2010
|
|
| 2010
|
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline.
Journal of Clinical Endocrinology and Metabolism.
95:4133-4160.
2010
|
|
| 2010
|
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Journal of Clinical Endocrinology and Metabolism.
95:4985-4992.
2010
|
|
| 2010
|
Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation.
Fertility and Sterility.
94.
2010
|
|
| 2010
|
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative..
International Journal of Pediatric Endocrinology.
2010:275213.
2010
|
|
| 2010
|
Nonclassic congenital adrenal hyperplasia..
International Journal of Pediatric Endocrinology.
2010:625105.
2010
|
|
| 2010
|
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: Role of tumor necrosis factor-α.
Journal of Clinical Endocrinology and Metabolism.
95:935-942.
2010
|
|
| 2010
|
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis study.
Journal of Clinical Endocrinology and Metabolism.
95:4432-4440.
2010
|
|
| 2010
|
Variants in the HMG-CoA reductase (HMGCR) gene influence component phenotypes in polycystic ovary syndrome.
Fertility and Sterility.
94.
2010
|
|
| 2009
|
From the eye of the nurses: 360-degree evaluation of residents.
Journal of Continuing Education in the Health Professions.
29:105-110.
2009
|
|
| 2009
|
Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.
European Journal of Endocrinology.
161:405-409.
2009
|
|
| 2009
|
A faculty and resident development program to improve learning and teaching skills..
Journal of graduate medical education.
1:127-131.
2009
|
|
| 2009
|
Total estrogen time and obstructive coronary disease in women: Insights fromthe NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Journal of Women's Health.
18:1315-1322.
2009
|
|
| 2009
|
Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS.
Fertility and Sterility.
92:643-647.
2009
|
|
| 2009
|
Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-h295r adrenocortical cell line.
Fertility and Sterility.
92:793-797.
2009
|
|
| 2009
|
Fifteen-year trend in the use of reproductive surgery in women in the United States.
Fertility and Sterility.
92:727-735.
2009
|
|
| 2009
|
Reply.
American Journal of Obstetrics and Gynecology.
201.
2009
|
|
| 2009
|
Reply of the Authors: Criteria for the polycystic ovary syndrome.
Fertility and Sterility.
92.
2009
|
|
| 2009
|
Visually scoring hirsutism.
Human Reproduction Update.
16:51-64.
2009
|
|
| 2009
|
Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells.
Fertility and Sterility.
91:2551-2556.
2009
|
|
| 2009
|
Reply of the Authors: Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.
Fertility and Sterility.
91.
2009
|
|
| 2009
|
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.
Fertility and Sterility.
91:1848-1852.
2009
|
|
| 2009
|
First evidence of genetic association between AKT2 and polycystic ovary syndrome (Diabetes Care (2008) 31, (2284-2287)).
Diabetes Care.
32:968.
2009
|
|
| 2009
|
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
Fertility and Sterility.
91:456-488.
2009
|
|
| 2009
|
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
94:3282-3288.
2009
|
|
| 2009
|
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17β-hydroxysteroid dehydrogenase gene.
Journal of Clinical Endocrinology and Metabolism.
94:5034-5038.
2009
|
|
| 2008
|
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3.
Fertility and Sterility.
90:2291-2297.
2008
|
|
| 2008
|
Use of metformin in polycystic ovary syndrome.
American Journal of Obstetrics and Gynecology.
199:596-609.
2008
|
|
| 2008
|
Effect of oral estrogen on substrate utilization in postmenopausal women.
Fertility and Sterility.
90:1275-1278.
2008
|
|
| 2008
|
Metformin Use in Polycystic Ovary Syndrome: Metabolic Benefits and Diabetes Prevention.
American Journal of Medicine.
121.
2008
|
|
| 2008
|
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome.
Therapeutics and Clinical Risk Management.
4:487-492.
2008
|
|
| 2008
|
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
93:2909-2912.
2008
|
|
| 2008
|
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
93:1939-1945.
2008
|
|
| 2008
|
Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462)).
Human Reproduction.
23:1474.
2008
|
|
| 2008
|
Diagnosing the diagnosis: Why we must standardize the defining features of polycystic ovary syndrome.
Annals of Clinical Biochemistry.
45:3-5.
2008
|
|
| 2008
|
FEM1A and FEM1B: Novel candidate genes for polycystic ovary syndrome.
Human Reproduction.
23:2842-2849.
2008
|
|
| 2008
|
First evidence of genetic association between AKT2 and polycystic ovary syndrome.
Diabetes reviews (Alexandria, Va.).
31:2284-2287.
2008
|
|
| 2008
|
Impact of obesity on the risk for polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
93:162-168.
2008
|
|
| 2008
|
Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
93:300-303.
2008
|
|
| 2008
|
Polycystic ovary syndrome is a family affair.
Journal of Clinical Endocrinology and Metabolism.
93:1579-1581.
2008
|
|
| 2008
|
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation.
Journal of Clinical Endocrinology and Metabolism.
93:1276-1284.
2008
|
|
| 2008
|
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
Journal of Clinical Endocrinology and Metabolism.
93:4268-4275.
2008
|
|
| 2008
|
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome.
Human Reproduction.
23:1214-1219.
2008
|
|
| 2008
|
Socioeconomic and Racial Predictors of Undergoing Laparoscopic Hysterectomy for Selected Benign Diseases: Analysis of 341 487 Hysterectomies.
Journal of Minimally Invasive Gynecology.
15:11-15.
2008
|
|
| 2007
|
The adrenal and polycystic ovary syndrome.
Reviews in Endocrine and Metabolic Disorders.
8:331-342.
2007
|
|
| 2007
|
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.
Fertility and Sterility.
87:1473-1476.
2007
|
|
| 2007
|
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
Fertility and Sterility.
87:862-869.
2007
|
|
| 2007
|
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters: Commentary.
Obstetrical and Gynecological Survey.
62:245-247.
2007
|
|
| 2007
|
Diagnosis of polycystic ovary syndrome.
Clinical Obstetrics and Gynecology.
50:168-177.
2007
|
|
| 2007
|
Brief report: The age-associated decline of androgens in reproductive age and menopausal black and white women.
Journal of Clinical Endocrinology and Metabolism.
92:4730-4733.
2007
|
|
| 2007
|
Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters.
American Journal of Obstetrics and Gynecology.
196:398.e1-398.e6.
2007
|
|
| 2007
|
Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
92:2659-2664.
2007
|
|
| 2007
|
Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement.
Journal of Clinical Endocrinology and Metabolism.
92:405-413.
2007
|
|
| 2006
|
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
Fertility and Sterility.
86:1688-1693.
2006
|
|
| 2006
|
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005.
Fertility and Sterility.
86:1318-1320.
2006
|
|
| 2006
|
Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.
Fertility and Sterility.
86:411-417.
2006
|
|
| 2006
|
Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation.
Fertility and Sterility.
86:484-486.
2006
|
|
| 2006
|
A twenty-first century research agenda for polycystic ovary syndrome
2006
|
|
| 2006
|
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome
2006
|
|
| 2006
|
Family size in women with polycystic ovary syndrome.
Fertility and Sterility.
85:1837-1839.
2006
|
|
| 2006
|
Preface
2006
|
|
| 2006
|
Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutism.
Journal of Clinical Endocrinology and Metabolism.
91:1345-1350.
2006
|
|
| 2006
|
Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature.
Journal of Clinical Endocrinology and Metabolism.
91:781-785.
2006
|
|
| 2006
|
How prevalent is metabolic syndrome in women with polycystic ovary syndrome?.
Nature Reviews Endocrinology.
2:132-133.
2006
|
|
| 2006
|
Role of diet in the treatment of polycystic ovary syndrome.
Fertility and Sterility.
85:679-688.
2006
|
|
| 2006
|
Reply of the Author [2].
Fertility and Sterility.
85:530.
2006
|
|
| 2006
|
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
Fertility and Sterility.
86:S7.
2006
|
|
| 2006
|
Disparate access: The disproportionality of African American students with disabilities across educational environments.
Exceptional Children.
72:411-424.
2006
|
|
| 2006
|
Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline.
Journal of Clinical Endocrinology and Metabolism.
91:4237-4245.
2006
|
|
| 2006
|
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
91:48-53.
2006
|
|
| 2006
|
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Journal of Clinical Endocrinology and Metabolism.
91:3451-3456.
2006
|
|
| 2006
|
Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
Journal of Clinical Endocrinology and Metabolism.
91:4085-4091.
2006
|
|
| 2005
|
What's the best way to diagnose insulin resistance and hyperinsulinemia?.
Contemporary OB/GYN.
50:66-74.
2005
|
|
| 2005
|
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study.
Journal of Clinical Endocrinology and Metabolism.
90:6072-6076.
2005
|
|
| 2005
|
Polycystic ovary syndrome in Mexican-Americans: Prevalence and association with the severity of insulin resistance.
Fertility and Sterility.
84:766-769.
2005
|
|
| 2005
|
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span.
Journal of Clinical Endocrinology and Metabolism.
90:4650-4658.
2005
|
|
| 2005
|
Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in Vitro: Relevance to polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
90:4852-4857.
2005
|
|
| 2005
|
Phenotypic spectrum of polycystic ovary syndrome: Clinical and biochemical characterization of the three major clinical subgroups.
Fertility and Sterility.
83:1717-1723.
2005
|
|
| 2005
|
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
Clinical Endocrinology.
62:644-649.
2005
|
|
| 2005
|
Diagnostic criteria for polycystic ovary syndrome: A reappraisal.
Fertility and Sterility.
83:1343-1346.
2005
|
|
| 2005
|
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
90:66-71.
2005
|
|
| 2005
|
Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.
Fertility and Sterility.
83:371-375.
2005
|
|
| 2005
|
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.
Fertility and Sterility.
83:1454-1460.
2005
|
|
| 2004
|
Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.
Journal of Clinical Epidemiology.
57:1279-1287.
2004
|
|
| 2004
|
The prevalence of androgen excess among patients with minimal unwanted hair growth.
American Journal of Obstetrics and Gynecology.
191:1914-1920.
2004
|
|
| 2004
|
Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
Journal of Clinical Endocrinology and Metabolism.
89:5558-5562.
2004
|
|
| 2004
|
Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Fertility and Sterility.
82:973-975.
2004
|
|
| 2004
|
Advances in the evaluation and treatment of unwanted hair growth.
Patient care.
38:23-28.
2004
|
|
| 2004
|
The prevalence and features of the polycystic ovary syndrome in an unselected population.
Journal of Clinical Endocrinology and Metabolism.
89:2745-2749.
2004
|
|
| 2004
|
Androgen Excess in Women: Experience with over 1000 Consecutive Patients.
Journal of Clinical Endocrinology and Metabolism.
89:453-462.
2004
|
|
| 2004
|
Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Fertility and Sterility.
81:126-131.
2004
|
|
| 2004
|
Early adrenarche in normal prepubertal girls: A prospective longitudinal study.
Journal of Pediatric Endocrinology and Metabolism.
17:1231-1237.
2004
|
|
| 2004
|
Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
Fertility and Sterility.
81:120-125.
2004
|
|
| 2004
|
PCOS: A diagnostic challenge
2004
|
|
| 2004
|
Potential cofounders in the laparoscopic detection of endometriosis [12] (multiple letters).
Fertility and Sterility.
81:1722-1723.
2004
|
|
| 2003
|
PCOS and normal menses: Another point of view.
Contemporary OB/GYN.
48:62.
2003
|
|
| 2003
|
The effectiveness of the interview for predicting the presence of polycystic ovary syndrome.
Gynecological Endocrinology.
17:449-454.
2003
|
|
| 2003
|
Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone.
Journal of Clinical Endocrinology and Metabolism.
88:5137-5144.
2003
|
|
| 2003
|
Polycystic ovary syndrome and ovulation induction
2003
|
|
| 2003
|
21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia: The Great Pretender.
Seminars in Reproductive Medicine.
21:295-300.
2003
|
|
| 2003
|
Androgen excess is the key element in polycystic ovary syndrome.
Fertility and Sterility.
80:252-254.
2003
|
|
| 2003
|
We should avoid the indiscriminate use of insulin sensitizers in women with polycystic ovary syndrome.
Fertility and Sterility.
80:264-265.
2003
|
|
| 2003
|
The evaluation and management of hirsutism..
Obstetrics and Gynecology.
101:995-1007.
2003
|
|
| 2003
|
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
Fertility and Sterility.
79:932-937.
2003
|
|
| 2003
|
Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate.
Fertility and Sterility.
80:1450-1453.
2003
|
|
| 2003
|
The evaluation and management of hirsutism.
Obstetrics and Gynecology.
101:995-1007.
2003
|
|
| 2003
|
The role of the adrenal cortex in polycystic ovary syndrome.
Infertility and Reproductive Medicine Clinics of North America.
14:557-568.
2003
|
|
| 2002
|
Adrenal androgens in the polycystic ovary syndrome.
Current Opinion in Endocrinology, Diabetes and Obesity.
9:469-474.
2002
|
|
| 2002
|
Advances in the evaluation and treatment of unwanted hair growth.
Emergency medicine.
47:98-106.
2002
|
|
| 2002
|
Advances in the evaluation and treatment of unwanted hair growth.
Contemporary OB/GYN.
47:98-106.
2002
|
|
| 2002
|
Role of reproductive surgeons and the Society of Reproductive Surgeons.
Fertility and Sterility.
78:916-917.
2002
|
|
| 2002
|
Exploring the relationship between PCOS and Type 2 diabetes mellitus.
References en gynecologie obstetrique.
9:29-33.
2002
|
|
| 2002
|
Editorial: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling.
Journal of Clinical Endocrinology and Metabolism.
87:4085-4087.
2002
|
|
| 2002
|
Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome.
Fertility and Sterility.
77:1125-1127.
2002
|
|
| 2002
|
Laser hair reduction in the hirsute patient: A critical assessment.
Human Reproduction Update.
8:169-181.
2002
|
|
| 2002
|
Adrenal progestogen and androgen production in 21-hydroxylase-deficient nonclassic adrenal hyperplasia is partially independent of adrenocorticotropic hormone stimulation.
Fertility and Sterility.
77:750-753.
2002
|
|
| 2002
|
Should employer-sponsored health insurance benefits be made public?.
Fertility and Sterility.
77:216-217.
2002
|
|
| 2002
|
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
Fertility and Sterility.
77:1095-1105.
2002
|
|
| 2001
|
Troglitazone use in polycystic ovary syndrome [4].
Journal of Clinical Endocrinology and Metabolism.
86:5090-5091.
2001
|
|
| 2001
|
Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: Preliminary studies.
Fertility and Sterility.
76:730-735.
2001
|
|
| 2001
|
Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones.
Fertility and Sterility.
76:823-825.
2001
|
|
| 2001
|
Adrenocortical secretion of dehydroepiandrosterone in healthy women: Highly variable response to adrenocorticotropin.
Journal of Clinical Endocrinology and Metabolism.
86:2513-2517.
2001
|
|
| 2001
|
Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin..
Journal of Clinical Endocrinology and Metabolism.
86:2513-2517.
2001
|
|
| 2001
|
Hyperandrogenemia in patients presenting with acne.
Fertility and Sterility.
75:889-892.
2001
|
|
| 2001
|
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial.
Journal of Clinical Endocrinology and Metabolism.
86:1626-1632.
2001
|
|
| 2001
|
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial..
Journal of Clinical Endocrinology and Metabolism.
86:1626-1632.
2001
|
|
| 2001
|
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.
Fertility and Sterility.
75:53-58.
2001
|
|
| 2001
|
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome.
Fertility and Sterility.
75:625-628.
2001
|
|
| 2001
|
Facial and abdominal hair growth in hirsutism: A computerized evaluation.
Journal of the American Academy of Dermatology.
45:846-850.
2001
|
|
| 2001
|
Infertility treatment before assisted reproductive techniques.
Ginecologia y obstetricia de Mexico.
69:167-171.
2001
|
|
| 2001
|
Ovarian hormones and adrenal androgens during a woman’s life span.
Journal of the American Academy of Dermatology.
45:S105-S115.
2001
|
|
| 2001
|
Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome.
American Journal of Obstetrics and Gynecology.
185:1381-1387.
2001
|
|
| 2001
|
The role of the adrenal cortex in polycystic ovary syndrome.
Obstetrics and Gynecology Clinics of North America.
28:63-75.
2001
|
|
| 2000
|
A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome.
Fertility and Sterility.
74:1237-1240.
2000
|
|
| 2000
|
Family history as a risk factor for the polycystic ovary syndrome.
Journal of Pediatric Endocrinology and Metabolism.
13:1303-1306.
2000
|
|
| 2000
|
Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.
Journal of Clinical Endocrinology and Metabolism.
85:48-54.
2000
|
|
| 2000
|
Idiopathic hirsutism.
Endocrine Reviews.
21:347-362.
2000
|
|
| 2000
|
Examination of the chin or lower abdomen only for the prediction of hirsutism.
Fertility and Sterility.
74:980-983.
2000
|
|
| 2000
|
The time has come to simplify the evaluation of the hirsute patient.
Fertility and Sterility.
74:870-872.
2000
|
|
| 2000
|
Adrenocortical hyperresponsivity to adrenocorticotropic hormone: A mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Fertility and Sterility.
74:329-334.
2000
|
|
| 2000
|
Idiopathic hirsutism..
Endocrine Reviews.
21:347-362.
2000
|
|
| 2000
|
Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico.
Fertility and Sterility.
74:59-62.
2000
|
|
| 2000
|
21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study.
American Journal of Obstetrics and Gynecology.
183:1468-1474.
2000
|
|
| 2000
|
A multicenter study of women with nonclassical congenital adrenal hyperplasia: Relationship between genotype and phenotype.
Molecular Genetics and Metabolism.
71:527-534.
2000
|
|
| 2000
|
Adrenal androgen excess in the polycystic ovary syndrome.
Endocrinologist.
10:245-254.
2000
|
|
| 1999
|
11β-Hydroxyandrostenedione and δ5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Fertility and Sterility.
72:996-1000.
1999
|
|
| 1999
|
Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: A prospective study.
Fertility and Sterility.
72:915-925.
1999
|
|
| 1999
|
Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists
1999
|
|
| 1999
|
Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group.
1999
|
|
| 1999
|
Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
1999
|
|
| 1999
|
Adrenal androgen excess in hyperandrogenism: Relation to age and body mass.
Fertility and Sterility.
71:671-674.
1999
|
|
| 1999
|
Impact of architectural disruption on adrenocortical steroidogenesis in vitro..
Journal of Clinical Endocrinology and Metabolism.
84:1017-1021.
1999
|
|
| 1999
|
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level..
Journal of Clinical Endocrinology and Metabolism.
84:946-950.
1999
|
|
| 1999
|
Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome.
Fertility and Sterility.
71:436-438.
1999
|
|
| 1999
|
Impact of architectural disruption on adrenocortical steroidogenesis in vitro.
Journal of Clinical Endocrinology and Metabolism.
84:1017-1021.
1999
|
|
| 1999
|
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Journal of Clinical Endocrinology and Metabolism.
84:946-950.
1999
|
|
| 1999
|
Prevalence of 3β-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess.
American Journal of Obstetrics and Gynecology.
181:596-600.
1999
|
|
| 1999
|
Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: A populational study.
Gynecological Endocrinology.
13:394-400.
1999
|
|
| 1998
|
Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Journal of Clinical Endocrinology and Metabolism.
83:2317-2323.
1998
|
|
| 1998
|
Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study.
Journal of Clinical Endocrinology and Metabolism.
83:3078-3082.
1998
|
|
| 1998
|
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).
Journal of Clinical Endocrinology and Metabolism.
83:1976-1987.
1998
|
|
| 1998
|
The effect of 17β-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women.
Journal of Clinical Endocrinology and Metabolism.
83:519-524.
1998
|
|
| 1998
|
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study..
Journal of Clinical Endocrinology and Metabolism.
83:3078-3082.
1998
|
|
| 1998
|
Differential binding of and testosterone to SHBG: Relation to circulating estradiol levels
1998
|
|
| 1998
|
Idiopathic hirsutism: An uncommon cause of hirsutism in Alabama.
Fertility and Sterility.
70:274-278.
1998
|
|
| 1998
|
Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis..
Journal of Clinical Endocrinology and Metabolism.
83:2317-2323.
1998
|
|
| 1998
|
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)..
Journal of Clinical Endocrinology and Metabolism.
83:1976-1987.
1998
|
|
| 1998
|
Measurement of total serum testosterone levels using commercially available kits: High degree of between-kit variability.
Fertility and Sterility.
69:286-292.
1998
|
|
| 1998
|
Identification and characterization of cytosolic sulfotransferases in normal human endometrium.
Chemico-Biological Interactions.
109:329-339.
1998
|
|
| 1998
|
The development of the polycystic ovary syndrome: Family history as a risk factor.
Trends in Endocrinology and Metabolism.
9:55-58.
1998
|
|
| 1998
|
Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
Journal of Clinical Endocrinology and Metabolism.
83:3219-3224.
1998
|
|
| 1998
|
Effect of ovarian steroid production on adrenal steroidogenesis? [6] (multiple letters).
Fertility and Sterility.
70:1187-1189.
1998
|
|
| 1998
|
Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal.
Journal of Endocrinological Investigation.
21:707-720.
1998
|
|
| 1998
|
On the 'First International Symposium on the Developmental Aspects of Androgen Excess'.
Trends in Endocrinology and Metabolism.
9:45-46.
1998
|
|
| 1998
|
Role of the ovary in the adrenal androgen excess of hyperandrogenic women.
Fertility and Sterility.
69:851-859.
1998
|
|
| 1997
|
Evaluation of infertility: A cost effective approach.
References en gynecologie obstetrique.
5:315-320.
1997
|
|
| 1997
|
CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β- hydroxylase deficiency.
Human Molecular Genetics.
6:1829-1834.
1997
|
|
| 1997
|
Detection of CAH heterozygotes [5] (multiple letters).
Fertility and Sterility.
68:182-184.
1997
|
|
| 1997
|
Detection of CAH heterozygotes..
Fertility and Sterility.
68.
1997
|
|
| 1997
|
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
Journal of Clinical Endocrinology and Metabolism.
82:479-485.
1997
|
|
| 1997
|
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism..
Journal of Clinical Endocrinology and Metabolism.
82:479-485.
1997
|
|
| 1997
|
Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
Human Reproduction.
12:1138-1141.
1997
|
|
| 1997
|
Nonclassic adrenal hyperplasia..
Current therapy in endocrinology and metabolism.
6:175-178.
1997
|
|
| 1997
|
Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women.
Fertility and Sterility.
67:569-572.
1997
|
|
| 1996
|
Demystifying fallacies surrounding nonclassic adrenal hyperplasia.
Contemporary OB/GYN.
41:109-131.
1996
|
|
| 1996
|
The 21-hydroxylase-deficient adrenal hyperplasias: More than ACTH oversecretion.
Reproductive Sciences.
3:297-302.
1996
|
|
| 1996
|
Adrenal androgen production in response to adrenocorticotropin infusions in men.
Endocrine Research.
22:717-722.
1996
|
|
| 1995
|
SEX-HORMONE RESPONSE AFTER RESISTIVE TRAINING IN HEALTHY OLDER WOMEN
1995
|
|
| 1995
|
21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Endocrinologist.
5:297-303.
1995
|
|
| 1995
|
Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
Journal of Clinical Endocrinology and Metabolism.
80:400-405.
1995
|
|
| 1995
|
Advances in the diagnosis and treatment of the hirsute patient.
Current Opinion in Obstetrics and Gynecology.
7:344-350.
1995
|
|
| 1995
|
Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1–24) stimulation in hyperandrogenic women.
American Journal of Obstetrics and Gynecology.
172:1251-1256.
1995
|
|
| 1995
|
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized study.
Journal of Clinical Endocrinology and Metabolism.
80:3406-3411.
1995
|
|
| 1995
|
Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation.
American Journal of Obstetrics and Gynecology.
172:914-918.
1995
|
|
| 1995
|
Training, certification, and credentialing in gynecologic operative endoscopy.
Clinical Obstetrics and Gynecology.
38:313-318.
1995
|
|
| 1994
|
delta 5-Androstene-3 beta,17 beta-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile..
Fertility and Sterility.
62:321-326.
1994
|
|
| 1994
|
Clinical review 56: nonclassic adrenal hyperplasia: Current concepts.
Journal of Clinical Endocrinology and Metabolism.
78:810-815.
1994
|
|
| 1994
|
Editor's formulation: Towards a working classification of androgen excess disorders.
Seminars in Reproductive Medicine.
12:51-52.
1994
|
|
| 1994
|
Preface.
Seminars in reproductive endocrinology.
12.
1994
|
|
| 1994
|
Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women.
Journal of Clinical Endocrinology and Metabolism.
79:1747-1751.
1994
|
|
| 1994
|
The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: Therapeutic response.
Fertility and Sterility.
61:570-572.
1994
|
|
| 1994
|
Δ5-Androstene-3β,17β-diol in healthy eumenorrheic women: Relationship to body mass and hormonal profile.
Fertility and Sterility.
62:321-326.
1994
|
|
| 1993
|
Preface.
Seminars in reproductive endocrinology.
11:306.
1993
|
|
| 1993
|
Concordance of 21-hydroxylase gene ratio, human leukocyte antigen haplotyping and adrenal testing results in a family with late-onset adrenal hyperplasia
1993
|
|
| 1993
|
Microsurgery alone or with INTERCEED Absorbable Adhesion Barrier for pelvic sidewall adhesion re-formation. The INTERCEED (TC7) Adhesion Barrier Study Group II..
Journal of the American College of Surgeons.
177:135-139.
1993
|
|
| 1993
|
3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
American Journal of Obstetrics and Gynecology.
168:889-895.
1993
|
|
| 1993
|
Adrenocortical dysfunction in androgen excess.
Seminars in Reproductive Medicine.
11:353-358.
1993
|
|
| 1993
|
Credentialing for endoscopic surgery [5].
Fertility and Sterility.
60:381-382.
1993
|
|
| 1993
|
Editor's formulation - The late-onset adrenal hyperplasias: An example of molecular biology applied to the study of androgen excess disorders.
Seminars in Reproductive Medicine.
11:359-360.
1993
|
|
| 1993
|
Fertility and infertility: Editorial overview.
Current Opinion in Obstetrics and Gynecology.
5:225-227.
1993
|
|
| 1993
|
Laparoscopic surgery for ectopic pregnancies: Technology assessment and public health implications.
Fertility and Sterility.
59:487-498.
1993
|
|
| 1993
|
Microsurgery alone or with INTERCEED absorbable adhesion barrier for pelvic sidewall adhesion re-formation.
Surgery, gynecology & obstetrics.
177:135-139.
1993
|
|
| 1992
|
Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology.
Fertility and Sterility.
58:302-306.
1992
|
|
| 1992
|
Operative endoscopy: The pressing need for a structured training and credentialing process.
Fertility and Sterility.
58:1100-1102.
1992
|
|
| 1992
|
Pro-453 to ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency
1992
|
|
| 1991
|
11 beta-hydroxylase deficiency in hyperandrogenism..
Fertility and Sterility.
55:733-741.
1991
|
|
| 1991
|
Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.
Journal of Clinical Endocrinology and Metabolism.
73:1327-1331.
1991
|
|
| 1991
|
Adrenal androgens and reproductive aging in females.
Seminars in Reproductive Medicine.
9:249-260.
1991
|
|
| 1991
|
Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women.
Fertility and Sterility.
56:427-433.
1991
|
|
| 1991
|
Magnetic resonance imaging of the adrenal gland in women with late-onset adrenal hyperplasia.
Fertility and Sterility.
56:142-144.
1991
|
|
| 1991
|
No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease.
Fertility and Sterility.
56:1179-1182.
1991
|
|
| 1991
|
The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women.
Journal of Clinical Endocrinology and Metabolism.
72:1025-1030.
1991
|
|
| 1991
|
When is late-onset adrenal hyperplasia not late-onset adrenal hyperplasia?.
Journal of Pediatric and Adolescent Gynecology.
4:211-214.
1991
|
|
| 1990
|
Dexamethasone Receptor Levels in Palatal and Lung Fibroblasts of Adult A/J and C57BL/6J Mice: Relationship to Glucocorticoid-Induced Cleft Palate.
The Cleft palate journal.
27:388-392.
1990
|
|
| 1990
|
21-Hydroxylase deficiency in female hyperandrogenism: Screening and Diagnosis.
Obstetrical and Gynecological Survey.
45:132-133.
1990
|
|
| 1990
|
Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of acth dose, subject weight, and sampling time.
Journal of Clinical Endocrinology and Metabolism.
70:1273-1279.
1990
|
|
| 1990
|
Androgen-Insensitivity Syndrome: Long-Term Results of Surgical Vaginal Creation.
Journal of Gynecologic Surgery.
6:23-26.
1990
|
|
| 1990
|
Dexamethasone receptor levels in palatal and lung fibroblasts of adult A/J and C57BL/6J mice: Relationship to glucocorticoid-induced cleft palate
1990
|
|
| 1990
|
Late onset adrenal hyperplasia: Mutation at codon 282 of the functional 21-hydroxylase gene is not ubiquitous.
Fertility and Sterility.
54:819-823.
1990
|
|
| 1990
|
On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
Journal of Clinical Endocrinology and Metabolism.
70:431-436.
1990
|
|
| 1990
|
Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasia.
American Journal of Obstetrics and Gynecology.
162:633-638.
1990
|
|
| 1989
|
21-Hydroxylase Deficiency in Female Hyperandrogenism: Screening and Diagnosis.
Journal of Clinical Endocrinology and Metabolism.
69:577-584.
1989
|
|
| 1989
|
Adenomyosis: Current perspectives.
Obstetrics and Gynecology Clinics of North America.
16:221-235.
1989
|
|
| 1989
|
Postoperative recuperation: Relation to the extent of endoscopic surgery.
Fertility and Sterility.
51:1061-1064.
1989
|
|
| 1989
|
Reproductive endocrinologic alterations in female asymptomatic obesity.
Fertility and Sterility.
52:703-725.
1989
|
|
| 1989
|
The treatment of hyperandrogenism with oral contraceptives.
Seminars in Reproductive Medicine.
7:246-254.
1989
|
|
| 1988
|
Acute myometritis and chorioamnionitis during cesarean section of asymptomatic women.
American Journal of Obstetrics and Gynecology.
159:1137-1139.
1988
|
|
| 1988
|
The development and use of a standard symphysial-fundal height growth curve in the prediction of small for gestational age neonates.
International Journal of Gynecology and Obstetrics.
26:81-87.
1988
|
|
| 1987
|
Genital anomalies in childhood.
Clinical Obstetrics and Gynecology.
30:682-696.
1987
|
|
| 1986
|
Adenomyosis in pregnancy. A review
1986
|
|
| 1986
|
Congenital adrenal hyperplasia: Long-term results following vaginal reconstruction.
Fertility and Sterility.
46:1011-1014.
1986
|
|
| 1981
|
The Hispanic patient..
Pennsylvania medicine.
84:22-25.
1981
|
|
